In the Amazon Region, there is a virtual absence of severe malaria and few
fatal cases of naturally occurring Plasmodium falciparum
infections; this presents an
intriguing and underexplored area of research. In addition to the rapid
access of infected
persons to effective treatment, one cause of this phenomenon might be the
recognition
of cytoadherent variant proteins on the infected red blood cell (IRBC)
surface, including
the var gene encoded P. falciparum
erythrocyte membrane protein 1. In order to establish a link between
cytoadherence, IRBC surface antibody recognition and the presence or absence
of
malaria symptoms, we phenotype-selected four Amazonian P. falciparum
isolates and the laboratory strain 3D7 for their cytoadherence to CD36 and
ICAM1 expressed on CHO cells. We then mapped the dominantly expressed var
transcripts and tested whether antibodies from symptomatic or asymptomatic
infections showed a differential recognition of the IRBC surface. As controls, the
3D7 lineages expressing severe disease-associated phenotypes were used. We showed
that there was no profound difference between the frequency and intensity of
antibody recognition of the IRBC-exposed P. falciparum proteins
in symptomatic vs. asymptomatic infections. The 3D7 lineages,
which expressed severe malaria-associated phenotypes, were strongly recognised by
most, but not all plasmas, meaning that the recognition of these phenotypes is
frequent in asymptomatic carriers, but is not necessarily a prerequisite to
staying free of symptoms.